title: Lanreotide delays progression of neuroendocrine tumours.
authors.forename: Judith A
authors.initials: JA
authors.lastname: Gilbert
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D018450:Disease Progression; D018572:Disease-Free Survival; D004311:Double-Blind Method; D007414:Intestinal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D010456:Peptides, Cyclic / Q000008:administration & dosage; D011379:Prognosis; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: C060347:lanreotide; D010456:Peptides, Cyclic; D013004:Somatostatin